Sinphar Pharmaceutical Co. Ltd.(TW:1734)
NT$30.15+0.05 (+0.17%)
TW:1734
Sinphar Pharmaceutical Co. Ltd. financials statements
NT$30.15
At close:+0.05 (+0.17%)
Sinphar Pharmaceutical Co. Ltd. (1734) Financial Statements
Sinphar Pharmaceutical Co. Ltd. Financial Overview
Sinphar Pharmaceutical Co. Ltd.'s market cap is currently NT$6.07B. The company's EPS TTM is NT$1.86; its P/E ratio is 17.33; and it has a dividend yield of 3.13%. Sinphar Pharmaceutical Co. Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 3.37B | NT$ 3.15B | NT$ 2.96B | NT$ 2.86B | NT$ 2.43B |
| Gross Profit | NT$ 1.46B | NT$ 1.24B | NT$ 1.09B | NT$ 1.09B | NT$ 888.71M |
| Operating Income | NT$ 416.86M | NT$ 294.01M | NT$ 286.06M | NT$ 197.80M | NT$ -180.23M |
| EBITDA | NT$ 689.70M | NT$ 601.24M | NT$ 582.94M | NT$ 539.57M | NT$ 109.64M |
| Net Income | NT$ 365.75M | NT$ 304.70M | NT$ 375.17M | NT$ 224.64M | NT$ -38.13M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 994.63M | NT$ 1.18B | NT$ 1.08B | NT$ 1.24B | NT$ 1.24B |
| Total Assets | NT$ 6.15B | NT$ 6.30B | NT$ 6.25B | NT$ 6.19B | NT$ 6.22B |
| Total Debt | NT$ 1.51B | NT$ 1.90B | NT$ 1.95B | NT$ 1.91B | NT$ 2.13B |
| Net Debt | NT$ 645.77M | NT$ 827.06M | NT$ 870.53M | NT$ 675.96M | NT$ 939.62M |
| Total Liabilities | NT$ 2.44B | NT$ 2.75B | NT$ 2.85B | NT$ 2.97B | NT$ 3.14B |
| Stockholders' Equity | NT$ 3.44B | NT$ 3.26B | NT$ 3.10B | NT$ 2.93B | NT$ 2.72B |
| Cash Flow | |||||
| Free Cash Flow | NT$ 383.72M | NT$ 336.80M | NT$ -4.57M | NT$ 271.85M | NT$ -25.90M |
| Operating Cash Flow | NT$ 584.66M | NT$ 593.51M | NT$ 296.37M | NT$ 425.30M | NT$ 135.54M |
| Investing Cash Flow | NT$ -224.63M | NT$ -391.08M | NT$ -334.56M | NT$ -124.24M | NT$ -205.60M |
| Financing Cash Flow | NT$ -576.03M | NT$ -209.08M | NT$ -106.84M | NT$ -263.32M | NT$ 122.95M |
Currency in TWD
